2022 World Conference on Lung Cancer (ePosters)-EP14.05-022. The Drug Induced Interstitial Lung Disease in Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer

EP14.05-022. The Drug Induced Interstitial Lung Disease in Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer

Back to course

Pdf Summary

This document discusses a study on drug-induced interstitial lung disease (D-ILD) in combined chemoimmunotherapy for extensive-stage small cell lung cancer. The research was conducted by multiple departments and medical centers in Japan.<br /><br />The study aimed to determine the incidence rate and imaging pattern of D-ILD in patients undergoing combined chemoimmunotherapy for extensive-stage small cell lung cancer. The researchers collected data on the overall characteristics and CT characteristics of the patients, both with and without D-ILD. They also analyzed the progression-free survival (PFS) and overall survival (OS) rates in these patients.<br /><br />The results of the study revealed several important findings. Firstly, the incidence rate of D-ILD in patients undergoing combined chemoimmunotherapy for extensive-stage small cell lung cancer was determined. Additionally, the CT characteristics of patients with and without D-ILD were compared. The researchers also analyzed the PFS and OS rates in patients with and without D-ILD using Kaplan-Meier curves.<br /><br />Based on the data collected, the researchers concluded that drug-induced interstitial lung disease can occur in patients receiving combined chemoimmunotherapy for extensive-stage small cell lung cancer. The study provides valuable information about the incidence rate and imaging pattern of this side effect, which can help guide clinical practice.<br /><br />In summary, this study highlights the occurrence of D-ILD in patients undergoing combined chemoimmunotherapy for extensive-stage small cell lung cancer. The findings underscore the importance of monitoring for this side effect and providing appropriate management strategies for patients.

Asset Subtitle

Rei Takamiya

Meta Tag

Speaker Rei Takamiya

Topic Small Cell Lung Cancer and Neuro-endocrine Tumours - RW/SOC

Keywords

drug-induced interstitial lung disease

chemoimmunotherapy

extensive-stage small cell lung cancer

incidence rate

imaging pattern

CT characteristics

progression-free survival

overall survival

Kaplan-Meier curves

clinical practice